МЕХТА Вимал Д. (US),РАСТЕЛЛИ Лука (US),САПРА Апарна Каточх (IN)
申请号：
RU2018105985
公开号：
RU2018105985A
申请日:
2016.07.18
申请国别(地区):
RU
年份:
2019
代理人:
摘要：
The present invention discloses a method of treating, preventing or ameliorating tumor growth by administering a therapeutic agent that selectively inhibits dipeptidyl peptidase including fibroblast activation protein and dipeptidyl peptidase 8/9 in combination with an immune checkpoint inhibitor. The method specifically discloses use of Talabostat in combination with an immune checkpoint inhibitor, its pharmaceutical composition and process of preparing such composition.
